Cite

HARVARD Citation

    Utebay, D. et al. (2021). Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report. European heart journal. 5 (10), p. . [Online]. 
  
Back to record